Axon

Arcadis is the world's leading company delivering sustainable design, engineering, and consultancy solutions for natural and built assets. With more than 36,000 people active in over 30 countries, we bring together the best minds from around the world to deliver intelligent products and solutions across the environment, energy, water, buildings, transport and infrastructure sectors. Our work has helped more than a third of the world's communities become more resilient, and we support over 40,000 client projects annually, generating gross revenues of €5bn in 2024. Founded in 1888 as a land reclamation business in the Netherlands, Arcadis has evolved through more than 135 years of innovation and strategic acquisitions into a global industry leader. We are ranked in the top 2% in our sector by Sustainalytics for ESG Risk Rating and in the top 2% of firms by EcoVadis for sustainable practices integration. Our four global business areas - Places, Mobility, Resilience, and Intelligence - enable us to deliver transformative projects that improve quality of life, from reducing flood risks in the Netherlands to securing clean drinking water across more than 30 U.S. states, from creating sustainable legacies during the Paris Olympics to revolutionizing urban transit with metro systems from Sydney to Toronto.

In 1923, Salomon van Zwanenberg founded NV Organon in Oss, Netherlands, establishing a pharmaceutical company that would become synonymous with advances in women's health. The original Organon pioneered innovations in contraception and stood at the forefront of reproductive health for decades. Nearly a century later, in 2021, a new independent company called Organon emerged through a strategic spinoff from Merck (known as MSD outside the U.S. and Canada), carrying forward this rich legacy while forging a new path dedicated to the health of women worldwide. Today, Organon operates as a global healthcare company with approximately 10,000 employees across nearly 60 countries, serving more than 140 markets with a diverse portfolio of over 60 medicines and devices. The company's mission centers on delivering impactful medicines and solutions for a healthier every day, with a focused strategy across three core business areas: Women's Health, Biosimilars, and Established Brands. By addressing health conditions that are unique to women, affect women disproportionately, or impact women differently - from contraception and fertility to cardiovascular disease and respiratory conditions - Organon envisions and actively works toward creating a better and healthier every day for every woman, recognizing that advancing women's health advances the health of society as a whole.

Accelleron is a global technology leader in high power turbocharging, fuel injection, and digital solutions for heavy-duty applications, with a remarkable heritage spanning 100 years. The company pioneered the world's first industrial turbocharger in 1924 through its predecessor BBC, establishing a legacy of innovation that continues today. With approximately 3,000 employees across more than 100 locations in over 50 countries, Accelleron serves as a trusted partner to the marine, power generation, oil and gas, and rail industries. The company's technologies support engines ranging from 0.5 to 80+ MW, helping customers reduce fuel consumption, lower emissions, and maximize operational efficiency. Since spinning off from ABB in October 2022, Accelleron has accelerated its focus on sustainability and the energy transition. The company maintains market leadership with 40-60% market shares across various turbocharger segments, supported by an installed base of 180,000 units requiring regular servicing. Accelleron's global service network, combined with cutting-edge digital solutions and expertise in turbocharging technology, positions the company at the forefront of decarbonization efforts in heavy-duty industries. Their commitment to innovation is backed by consistently high profit margins, strong cash flow generation, and strategic investments in research and development.

Every day, millions of people face serious health challenges that limit their ability to live fully. Abbott exists to change that by developing life-changing technologies that address the world's most pressing health needs. From the 30-year-old physician Dr. Wallace C. Abbott, who founded the company in 1888 by creating more accurate and reliable medicines in his Chicago drugstore, to today's global team of 115,000 employees, Abbott has remained driven by a singular purpose: helping people live healthier, fuller lives through breakthrough science and innovation. Abbott's portfolio of technologies spans the entire spectrum of healthcare, serving people in more than 160 countries. The company revolutionized diabetes care with the FreeStyle Libre continuous glucose monitoring system, has been a leader in cardiovascular health for decades, pioneered diagnostic testing including the first licensed HIV blood test, and provides science-based nutrition products that support growth and recovery at every stage of life. With 135+ years of innovation behind them and recognition as one of Fortune's Most Admired Companies every year since 1984, Abbott continues to push boundaries - from developing the AVEIR DR leadless pacemaker to creating biowearables like Lingo that help people understand their health and wellness.

At NewForesight, we believe that the world's most complex sustainability challenges can be solved through bold, systemic change. Founded in 2008, we combine systems thinking, market-based solutions, and hands-on implementation to drive lasting transitions across food, energy, circularity, inclusive economies, and health. Our team of consultants, analysts, and strategists work from offices in Utrecht and Cape Town, partnering with leaders across businesses, financial institutions, and governments to design market systems where sustainability becomes the competitive norm. We approach sustainability transitions as collaborative, cross-sector transformations rather than isolated projects. Through our five interconnected domains - TransMission for system analysis and transition design, Sector Transformation, Sustainable Sourcing & Value Chains, Transformative Finance & Investment, and Transformative Organisations - we help clients move from ambition to measurable impact. Having delivered over 200 transition programs across more than 20 sectors in 35+ countries, we bring deep expertise in convening stakeholders, creating shared visions, and designing governance models that make sustainability an integral part of how organizations operate.

Peraton is a next-generation national security and technology company that fearlessly solves the world's toughest challenges, employing more than 18,000 people across 150+ U.S. locations. With $7 billion in annual revenue, Peraton drives missions of consequence spanning the globe and extending to the farthest reaches of space - from supporting interplanetary spacecraft landings and thwarting dark web cyberattacks to combating global pandemics. The company's heritage spans more than 125 years, and in 2021 alone, Peraton grew sevenfold through strategic acquisitions to transform into the world's leading mission capability integrator. Trusted by the U.S. government's most critical agencies, Peraton holds landmark contracts including a $31.5 billion award to modernize the Federal Aviation Administration's Air Traffic Control System and a $2.69 billion Department of Homeland Security data center optimization contract. Operating across space, intelligence, cyber, defense, homeland security, citizen security, and health sectors, Peraton delivers ironclad assurances needed for near-term success and long-term national security sustainability. The company's applied research arm, Peraton Labs, employs 450+ scientists, engineers, and analysts - with 50% holding technical master's degrees and 30% holding doctorates - generating more than 470 patents across cybersecurity, analytics, photonics, and wireless technologies.